ACTRN12622000522718尚未招募1 期
Comparison of the efficacy of two triple therapy topical combinations in the treatment of melasma in adults
Michelle Rodrigues0 个研究点目标入组 20 人开始时间: 2022年4月1日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patient clinically diagnosed with melasma
- •- If patient is of childbearing age, she will be required to use a reliable contraceptive for at least 1 month and agree not to change her contraceptive status for the duration of the study
- •- Patient who has signed the written informed consent form for study participation
排除标准
- •- Women who are pregnant or breast-feeding or who are planning for pregnancy during the course of the study. (A urine b-HCG or urine dipstick test will be performed)
- •- Patient with another pigmentation disorder on the face.
- •- Patient with other dermatoses that may interfere with the evaluation or application of the products involved in the study.
- •- Patient who has used a depigmentation agent in the month prior to inclusion.
- •- Patient who has used a local corticosteroid on the skin, eyes, nose or mouth (inhaled corticosteroid) or systemic corticosteroids during the month prior to inclusion.
- •- Patient who has used local tretinoin or hydroquinone in the month prior to inclusion.
- •- Patient on chronic anti-inflammatory therapies (patient accepted into study if cumulative NSAID use is less than 10 days over the duration of the study).
- •- Patient with a clinically significant history of allergy, especially to the components of the products studied.
- •- Vulnerable persons including people under the age of 18 and those who are unable to take care of or protect themselves against harm or exploitation.
- •- Patient being in a situation that, in the investigator's opinion, may interfere with optimal participation in the study.
- •- Patient who is participating or has participated in another clinical drug trial in the month prior to inclusion.
- •- Patient who cannot communicate effectively with the investigator or who cannot follow the instructions involved in the study.
- •- Patient who is refusing to be photographed as part of the study.
- •- Patient who withdraws their informed consent from the study.
研究者
相似试验
招募中
3 期
Comparison of the effectiveness , TENS, embedding, acupuncture and drug therapy .IRCT20121228011912N7Mashhad University of Medical Sciences72
尚未招募
3 期
Comparing the effects of three therapeutic regimens prednisolone on platelet increase in patients with primary immune thrombocytopenic purpuraIRCT20230717058813N1Shahid Beheshti University of Medical Sciences75
尚未招募
3 期
Comparison of two antibiotic regimens in eradicating Helicobacter pyloriHelicobacter pylori infection.Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhereB96.81IRCT20210209050313N1Tehran University of Medical Sciences130
尚未招募
不适用
Comparison of triple therapy, sequential therapy, and concomitant quadruple therapy of Helicobacter pyloriDiseases of the digestive systemKCT0000703The Catholic University of Korea, Incheon St. Mary's Hospital510
已完成
不适用
The prospective trial to validate the superior efficacy of sequential therapy to standard therapy in Helicobacter pylori eradicatioDiseases of the digestive systemKCT0000014Daegu-Kyungpook Gastrointestinal Study Group348